Department of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria.
Reprod Biol Endocrinol. 2009 Dec 30;7:153. doi: 10.1186/1477-7827-7-153.
Our objective was to investigate luteinizing hormone, follicle-stimulating hormone, testosterone, and androstenedione as predicitve markers for ovulation after laparoscopic ovarian drilling.
We retrospectively analyzed 100 clompihen-resistant patients with the polycystic ovary syndrome who underwent laparoscopic ovarian drilling at our department. The main outcome measure was spontaneous postoperative ovulation within three months after laparoscopic ovarian drilling. In order to predict spontaneous ovulation, we tested the following parameters by use of a univariate followed by a multivariate regression model: Preoperative serum levels of LH, FSH, testosterone, and androstenedione as well as patients' age and body mass index. In addition, we focused on pregnancy and life birth rates.
Spontaneous ovulation was documented in 71/100 patients (71.0%). In a univariate and multivariate analysis, luteinizing hormone (OR 1.58, 95%CI: 1.30-1.92) and androstenedione (OR 3.03, 95%CI: 1.20-7.67), but not follicle-stimulating hormone and testosterone were independent predictors of ovulation. Using a cut-off for luteinizing hormone and androstenedione of 12.1 IU/l and 3.26 ng/ml, respectively, spontaneous ovulation was observed in 63/70 (90.0%) and 36/42 patients (85.7%) with elevated and in 8/30 (26.7%) and 35/58 (60.3%) patients with low luteinizing hormone and androstenedione levels, respectively. The sensitivity, specificity, positive and negative predictive values for luteinizing hormone and androstendione as predictors of spontaneous ovulation after ovarian drilling were 88.7% (95%CI: 79.0-95.0%), 75.9% (95%CI: 56.5-89.7%), 90.0% (95%CI: 80.5-95.8%), and 73.3% (95%CI: 54.1-87.7%) for luteinizing hormone, and 50.7% (95%CI: 38.6-62.8%), 79.3% (95%CI: 60.3-92.0%), 85.7% (95%CI: 71.5-94.6%), and 39.7% (95%CI: 27.0-53.4%) for androstenedione, respectively. Complete one-year follow-up was available for 74/100 patients (74%). We observed a one-year pregnancy rate and a resulting life-birth rate of 61% and 51%, respectively.
Luteinizing hormone and androstenedione prior to laparoscopic ovarian drilling are independent predictors of spontaneous ovulation within three months of surgery. We suggest to preferentially performing laparoscopic ovarian drilling in patients with high luteinizing hormone and androstenedione levels.
我们的目的是研究黄体生成素、卵泡刺激素、睾酮和雄烯二酮是否可作为腹腔镜卵巢打孔术后排卵的预测指标。
我们回顾性分析了在我院行腹腔镜卵巢打孔术的 100 例氯米酚抵抗的多囊卵巢综合征患者。主要观察指标为术后 3 个月内自发性排卵。为了预测自发性排卵,我们采用单变量和多变量回归模型分别检测了以下参数:术前血清 LH、FSH、睾酮和雄烯二酮水平以及患者年龄和体重指数。此外,我们还关注了妊娠率和活产率。
71/100 例(71.0%)患者发生自发性排卵。在单变量和多变量分析中,黄体生成素(OR 1.58,95%CI:1.30-1.92)和雄烯二酮(OR 3.03,95%CI:1.20-7.67),而不是卵泡刺激素和睾酮,是排卵的独立预测因子。使用黄体生成素和雄烯二酮的截断值分别为 12.1 IU/L 和 3.26ng/ml,在 70 例(90.0%)和 42 例(85.7%)高黄体生成素和雄烯二酮水平患者中观察到排卵,而在 30 例(26.7%)和 58 例(60.3%)低黄体生成素和雄烯二酮水平患者中分别观察到 8/30(26.7%)和 35/58(60.3%)例患者排卵。黄体生成素和雄烯二酮作为卵巢打孔术后自发性排卵预测因子的敏感性、特异性、阳性和阴性预测值分别为 88.7%(95%CI:79.0-95.0%)、75.9%(95%CI:56.5-89.7%)、90.0%(95%CI:80.5-95.8%)和 73.3%(95%CI:54.1-87.7%),而黄体生成素为 50.7%(95%CI:38.6-62.8%)、79.3%(95%CI:60.3-92.0%)、85.7%(95%CI:71.5-94.6%)和 39.7%(95%CI:27.0-53.4%),雄烯二酮分别为 85.7%(95%CI:71.5-94.6%)和 39.7%(95%CI:27.0-53.4%)。100 例患者中有 74/100 例(74%)完成了 1 年的完整随访。我们观察到 1 年妊娠率和活产率分别为 61%和 51%。
腹腔镜卵巢打孔术前的黄体生成素和雄烯二酮是术后 3 个月内自发性排卵的独立预测因子。我们建议优先对黄体生成素和雄烯二酮水平较高的患者行腹腔镜卵巢打孔术。